vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ACV Auctions Inc. (ACVA). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $183.6M, roughly 1.5× ACV Auctions Inc.). On growth, ACV Auctions Inc. posted the faster year-over-year revenue change (15.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 12.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
ACV Auctions Inc.ACVAEarnings & Financial Report
ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.
ACAD vs ACVA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $183.6M |
| Net Profit | $273.6M | — |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | -9.7% |
| Net Margin | 96.3% | — |
| Revenue YoY | 9.4% | 15.1% |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $183.6M | ||
| Q3 25 | $278.6M | $199.6M | ||
| Q2 25 | $264.6M | $193.7M | ||
| Q1 25 | $244.3M | $182.7M | ||
| Q4 24 | $259.6M | $159.5M | ||
| Q3 24 | $250.4M | $171.3M | ||
| Q2 24 | $242.0M | $160.6M | ||
| Q1 24 | $205.8M | $145.7M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $-24.5M | ||
| Q2 25 | $26.7M | $-7.3M | ||
| Q1 25 | $19.0M | $-14.8M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $-16.0M | ||
| Q2 24 | $33.4M | $-17.1M | ||
| Q1 24 | $16.6M | $-20.5M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | -9.7% | ||
| Q3 25 | 12.8% | -11.9% | ||
| Q2 25 | 12.2% | -3.7% | ||
| Q1 25 | 7.9% | -7.9% | ||
| Q4 24 | 59.1% | -16.2% | ||
| Q3 24 | 12.6% | -10.0% | ||
| Q2 24 | 12.6% | -11.6% | ||
| Q1 24 | 7.4% | -15.5% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | -12.3% | ||
| Q2 25 | 10.1% | -3.8% | ||
| Q1 25 | 7.8% | -8.1% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | -9.4% | ||
| Q2 24 | 13.8% | -10.6% | ||
| Q1 24 | 8.0% | -14.1% |
| Q4 25 | $1.61 | $-0.12 | ||
| Q3 25 | $0.42 | $-0.14 | ||
| Q2 25 | $0.16 | $-0.04 | ||
| Q1 25 | $0.11 | $-0.09 | ||
| Q4 24 | $0.86 | $-0.15 | ||
| Q3 24 | $0.20 | $-0.10 | ||
| Q2 24 | $0.20 | $-0.10 | ||
| Q1 24 | $0.10 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $271.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $429.7M |
| Total Assets | $1.6B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $271.5M | ||
| Q3 25 | $258.0M | $265.3M | ||
| Q2 25 | $253.6M | $258.4M | ||
| Q1 25 | $217.7M | $291.9M | ||
| Q4 24 | $319.6M | $224.1M | ||
| Q3 24 | $155.1M | $252.5M | ||
| Q2 24 | $177.1M | $215.0M | ||
| Q1 24 | $204.7M | $209.8M |
| Q4 25 | $1.2B | $429.7M | ||
| Q3 25 | $917.3M | $434.4M | ||
| Q2 25 | $822.4M | $448.8M | ||
| Q1 25 | $765.2M | $439.6M | ||
| Q4 24 | $732.8M | $440.0M | ||
| Q3 24 | $577.2M | $456.2M | ||
| Q2 24 | $516.7M | $457.6M | ||
| Q1 24 | $464.0M | $458.3M |
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $984.1M | ||
| Q3 24 | $976.9M | $1.0B | ||
| Q2 24 | $914.1M | $1.0B | ||
| Q1 24 | $855.1M | $1.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-12.4M |
| Free Cash FlowOCF − Capex | — | $-14.7M |
| FCF MarginFCF / Revenue | — | -8.0% |
| Capex IntensityCapex / Revenue | — | 1.2% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $69.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-12.4M | ||
| Q3 25 | $74.3M | $10.3M | ||
| Q2 25 | $64.0M | $13.7M | ||
| Q1 25 | $20.3M | $66.6M | ||
| Q4 24 | $40.4M | $-3.2M | ||
| Q3 24 | $63.2M | $21.1M | ||
| Q2 24 | $25.0M | $4.5M | ||
| Q1 24 | $29.1M | $43.0M |
| Q4 25 | — | $-14.7M | ||
| Q3 25 | $73.9M | $7.7M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $65.3M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $63.2M | $20.2M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $41.9M |
| Q4 25 | — | -8.0% | ||
| Q3 25 | 26.5% | 3.8% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 35.7% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | 25.2% | 11.8% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 28.8% |
| Q4 25 | — | 1.2% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
